BioMarin Pharmaceutical, Inc. (NASDAQ:BMRN)

CAPS Rating: 4 out of 5

The Company develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions.

Recs

1
Player Avatar kenhawk13f (67.08) Submitted: 3/28/2013 9:25:45 AM : Outperform Start Price: $60.44 BMRN Score: -13.67

Since I bought this stock it has gone up 139% and keeps growing.

Featured Broker Partners


Advertisement